 |
| Dean Reinke Deans’ Stroke Musing |
This was one of the more fascinating articles I've read mainly because it is for chronic rather than acute survivors. And it it would be one of those magical fixes. Like Peter Levines' stroke eliminator.
To view the multimedia assets associated with this release, please click Inflammation Identified as New Therapeutic Target Years After Stroke.
The study utilized a new method of delivery of etanercept, a potent biotechnology anti-inflammatory therapeutic. Etanercept has been a breakthrough for rheumatoid arthritis and other inflammatory disorders. It works by neutralizing tumor necrosis factor (TNF), a cytokine that initiates and amplifies inflammation. The therapeutic potential of etanercept in Alzheimer’s disease, traumatic brain injury, spinal cord injury, sciatica, and other neuroinflammatory disorders has attracted increasing attention(1).
Ask your doctor if you might be an off-label use for this. If s/he knows about this, you have a good up-to-date doctor. Looking at the paper for this I really doubt the ability of this. No proof that TNF was measured either before or afterward, and no rigorous therapist documentation, just mainly spousal comments.
I do wonder how many years after a stroke the tumor necrosis factor (TNF) is still around in the brain.
I'll add that to my question for stroke researchers.
See the original article:
in
No comments:
Post a Comment